The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Abstract
Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a paucity of adipose (fat) tissue which is evident at birth and is accompanied by a severe resistance to insulin, leading to hyperinsulinaemia, hyperglycaemia and enlarged fatty liver. We have developed a mouse model that mimics these features of CGL: the syndrome occurs in transgenic mice expressing a truncated version of a nuclear protein known as nSREBP-1c (for sterol-regulatory-element-binding protein-1c) under the control of the adipose-specific aP2 enhancer. Adipose tissue from these mice was markedly deficient in messenger RNAs encoding several fat-specific proteins, including leptin, a fat-derived hormone that regulates food intake and energy metabolism. Here we show that insulin resistance in our lipodystrophic mice can be overcome by a continuous systemic infusion of low doses of recombinant leptin, an effect that is not mimicked by chronic food restriction. Our results support the idea that leptin modulates insulin sensitivity and glucose disposal independently of its effect on food intake, and that leptin deficiency accounts for the insulin resistance found in CGL.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Shimomura et al. have demonstrated that leptin treatment reversed insulin resistance in a fat-specific aP2-SREBP-1c knockout mouse model of congenital generalized lipodystrophy (4).”
From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [4]
In the citing paper
“Taken together, these data suggest that intrahepatic and intramyocellular lipid lowering effects of leptin were mediated mostly by a reduction in energy intake, as opposed to a leptininduced increase in energy expenditure, although a lipolytic effect of leptin on these tissues cannot be ruled out (4, 28).”
From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [4]
In the citing paper
“Several lines of evidence from both humans and rodent models suggest that leptin deficiency contributes to insulin resistance and diabetes in this setting (139, 168, 169).”
From Leptin and the Central Nervous System Control of Glucose Metabolism (2011) · cites this paper as [168]
In the citing paper
“the diabetes phenotype of these lipodystrophic mice is also ameliorated by leptin administration via a mechanism that is, at least in part, independent of its effect on food intake and body weight (64, 168).”
From Leptin and the Central Nervous System Control of Glucose Metabolism (2011) · cites this paper as [168]
In the citing paper
“First in rodent models (5) and then in preliminary short-term studies in humans (6), it was shown that recombinant leptin administration could ameliorate dyslipidemia, insulin resistance, and diabetes.”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [5]
In the citing paper
“Moreover, leptin dramatically improves insulin sensitivity in human lipodystrophy and in lipodystrophic mouse models which are characterized by low serum leptin levels and by severe insulin resistance (Oral et al., 2002; Petersen et al., 2002; Shimomura et al., 1999).”
From Leptin-Dependent Control of Glucose Balance and Locomotor Activity by POMC Neurons (2009) · cites this paper as Shimomura et al., 1999
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citationADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism.Preprint
Kim, J. B., & Spiegelman, B. M. (1996) · Genes & Development · doi:10.1101/gad.10.9.1096 · Cited by 1,026
Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., & Brown, M. S. (1998) · Genes & Development · doi:10.1101/gad.12.20.3182 · Cited by 790
Self-citationLife without white fat: a transgenic mousePreprint
Moitra, J., Mason, M. M., Olive, M., Krylov, D. Y., Gavrilova, O., Marcus‐Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., et al. (1998) · Genes & Development · doi:10.1101/gad.12.20.3168 · Cited by 776
What if Minkowski Had Been Ageusic? An Alternative Angle on Diabetes
McGarry, J. D. (1992) · Science · doi:10.1126/science.1439783 · Cited by 657
Tontonoz, P., Kim, J. B., Graves, R. A., & Spiegelman, B. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4753-4759.1993 · Cited by 599
Regulation of fatty acid homeostasis in cells: Novel role of leptin
Unger, R. H., Zhou, Y.-T., & Orci, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2327 · Cited by 435
Shimomura, I., Shimano, H., Korn, B. S., Bashmakov, Y., & Horton, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35299 · Cited by 333
Self-citation
Cited by
Sorted by citations
Items 901–997 of 997
Proteomics Study of Palmitic Acid-induced Insulin Resistance in Adipocyte Secretome
Piumngam, K., Siripurkpong, P., Kongkhum, S., & Roytrakul, S. (2013) · Warasan Theknik Kanphaet
Ashley, D. T. (2010) · Dublin City University Open Access Institutional Repository (Dublin City University)
Resistencia a la insulina durante el envejecimiento: ¿un proceso mediado por leptina?
Baeza, J. (2005) · Monografías de la Real Academia Nacional de Farmacia
Glykogenspeichererkrankungen, Lipodystrophien und andere Fettgewebserkrankungen
Steinmetz, A., & Schmidt, H. (2006) · Springer eBooks · doi:10.1007/3-540-27385-9_42
Insulin Resistance, Diabetes and its Complications
Ng, D. S. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400011
Cailotto, C. (2006) · UvA-DARE (University of Amsterdam)
Lipodysregulation and Type 2 diabetes in TALLYHO/Jng Mice
Mostafa, O. A. (2006)
The role of adipocyte CREB in insulin resistance
van Eeuwijk, J. M. M. (2011) · Utrecht University Repository (Utrecht University)
Hormone-Sensitive Lipase - New roles in adipose tissue biology
Ström, K. (2008) · Lund University Publications (Lund University)
横田, 繁., & ヨコタ, シ. (2013) · SOKENDAI (Graduate University for Advanced Studies)
Deciphering mitochondrial and molecular pathology in Type 2 Diabetes Mellitus
van Tienen, F. H. J. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20110204ft
Regulation of renal brush-border glucose transport in response to metabolic dysregulation
Chichger, H. (2011) · UCL Discovery (University College London)
Experimental and genetic studies on podocyte molecules CD2AP and SHIP2 in diabetic nephropathy
Hyvönen, M. E. (2013) · Työväentutkimus Vuosikirja
¿Debemos incluir la determinación de la resistina en la práctica clínica?
Rubio, M. Á. (2003) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(03)74503-3
Effet anti-obésité des CLA : mythe ou réalité ?
Quignard‐Boulangé, A., Bouthegourd, J.-C., Yvan‐Charvet, L., Even, P. C., Besnard, P., & Martin, J. (2005) · Oléagineux Corps gras Lipides · doi:10.1051/ocl.2005.0045
Clinical Significance of Serum Leptin Levels in the Diagnosis of Fatty Liver
Hattori, K., Mochizuki, N., Koshibu, K., MINATO, Y., & Shiigai, T. (2006) · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE · doi:10.2185/jjrm.54.734
Food Restriction and the Accumulation of Fat in the Livers of Wistar Rats
de Moura, L. P. (2012) · The Open Nutrition Journal · doi:10.2174/1874288201206010035
A leptina e o seu impacto metabólico nas lipodistrofias
Lau, E., Freitas, P., Isabel, O. A., & Carvalho, D. M. (2014) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.1016/j.rpedm.2014.03.003
Macrophage infiltration and cytokine release in adipose tissue: angiogenesis or inflammation?
Wu, L. E., HOCKING, S. L., & James, D. E. (2010) · Diabetology International · doi:10.1007/s13340-010-0003-x
Vezyraki, A., Kapelouzouc, S., Fotiadisb, N., Theofilogiannakosa, M. S., & Gerou, E. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.008
RetractedIn vivo estimation of gluconeogenesis
Chacko, S. K. (2011) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Sutinen, J. (2003) · Työväentutkimus Vuosikirja
Aljwaid, H. (2015) · PEARL (University of Plymouth) · doi:10.24382/2587
Forero, M., & Antonio, S. (2006) · TDX (Tesis Doctorals en Xarxa)
Kim, E. S. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.4.263
Kiss1 neurons and Metabolic Sensing
Qiu, X. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
Leptina: funtzio fisiologiko garrantzitsuak dituen molekula
Zorita, S. (2010)
infusiondiet are corrected by an acute leptin Hepatic steatosis and plasma dyslipidemia induced by
Huang, W., Dedousis, N., Woods, J. A., Vieira‐Potter, V. J., Valentine, R. J., Wilund, K. R., Antao, N. N., Baynard, T., Takeda, E., Sawada, N., et al. (2015)
atualização Vias de Sinalização da Insulina
Zecchin, H. G., & Saad, M. J. A. (2002)
Huynh, F. K., Levi, J., Denroche, H. C., Gray, S. L., Voshol, P. J., Speck, M., Chua, S. C., Covey, S. D., & Kieffer, T. J. (2010)
TRANSPLANTATION OF ADIPOSE TISSUE AS A REPLACEMENT THERAPY
Ablamunits, V. G., & Klebanov, S. (2015) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2014-4-135-143
Modulação do metabolismo muscular da glicose pela ação hipotalâmica da leptina
Roman, E. A. D. F. R. (2011) · doi:10.47749/t/unicamp.2011.829153
Nutrient regulation of energy metabolism in relation to obesity and type 2 diabetes
Wensaas, A. J. (2010) · NORA - Norwegian Open Research Archives
Peroxisome proliferator activated receptor-gamma P465L mutation in diabetes and atherosclerosis
Pendse, A. A. (2010) · ProQuest Demo Repository
Esteatohepatitis no alcohólica Actualización
Lledó, Y. J. L. (2004)
Vu, B. G., Schlievert, P. M., Squier, C. A., Yahr, T. L., Horswill, A. R., & Apicella, M. A. (2014) · doi:10.17077/etd.y6n7p4ee
Modern science versus the stigma of
Friedman, M. J. (2004)
Unraveling Novel Leptin-Dependent Signaling Pathways in the Basomedial Hypothalamus.
Villanueva, E. C. (2010) · Deep Blue (University of Michigan)
INDICADORES DE SÍNDROME METABÓLICA EM MENINAS
Filho, M., & Araraquara, C. D. (2005)
Chapter 6. Syndromes of Extreme Insulin Resistance
Grunberger, G., & Alrefai, H. (2004)
The role of leptin in the regulation of glucose homeostasis
Levi, J. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071042
Effect of Leptin on Fatless Mice
Shimomura, I. (2002) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-642-18999-9_9
Self-citationRodríguez, A. J., Neeman, T. M., Giles, A. G., Mastronardi, C. A., & Paz-Filho, G. (2014)
Cheng, L. (2015) · Research Online (University of Wollongong)
[Diabetes and the metabolic syndrome].
Yamauchi, T., & Kadowaki, T. (2006) · Folia Pharmacologica Japonica · doi:10.1254/fpj.128.133
Yalamanchi, S., Brown, T. T., & Dobs, A. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_38
Insulin resistance in diabetes
Balasubramanian, R., & Taylor, R. (2004) · CRC Press eBooks · doi:10.3109/9780203640562-5
Oligomeric Composition of Adiponectin and Obesity
Bobbert, & Spranger, J. (2007) · Oxidative stress and disease · doi:10.1201/9781420043792.ch10
Bowers, J. M. (2000) · Modern nutrition · doi:10.1201/9781420042290.ch10
Zucker fatty rats Development of insulin resistance and hyperphagia in
Durham, H. A., & Truett, G. E. (2016)
Metabolische Korrektur mit Leptin
Miehle, K., Stümvoll, M., Faßhauer, M., Kieß, W., & Kapellen, T. M. (2012) · Info Diabetologie · doi:10.1007/s15034-012-0225-z
Management of Insulin Resistance with Chinese Herbs
Yin, J., & Ye, J. (2008) · Modern nutrition · doi:10.1201/9781420059724.ch16
Leptin as a Vasoactive Adipokine
Lolmède, K., Curat, C. A., Bouloumié, A., Miranville, A., & Sengenès, C. (2007) · CRC Press eBooks · doi:10.1201/9781420005479.ch8
METRELEPTINA: TRATAMIENTO PARA LAS COMPLICACIONES METABÓLICAS DE LA LIPODISTROFIA GENERALIZADA.
Lima-Martínez, M. M. (2016) · Actualidad Contable FACES
Waring, J. F., & Rondinone, C. M. (2004) · CRC Press eBooks · doi:10.1201/9781420030921.ch17
糖尿病 診断から自己管理まで Ｉ． 診断と病態 ３． 糖尿病の病態 インスリンの分泌障害か抵抗性か ２） 抵抗性
Ogawa, W. (2000) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.89.1512
The Role Of Adipose Tissue In Glucose Homeostasis
Lyngdoh, J., Marbaniang, E., & Sangma, M. (2016) · International Journal Of Medical Science And Clinical Invention · doi:10.18535/ijmsci/v3i9.01
特集 脂肪細胞とインスリン抵抗性 レプチン (Leptin)
佳宏, 小., & Nakao, K. (2003) · 糖尿病 · doi:10.11213/tonyobyo1958.46.730
Kiràly, M. A. (2008) · TSpace (University of Toronto)
Woo, J. G. (2004) · OhioLink ETD Center (Ohio Library and Information Network)
Late-Breaking Clinical Trial Report
Chan, J. L., Lutz, K., Cochran, E. K., Huang, W., Peters, Y., Weyer, C., & Görden, P. (2011)
Central Nervous System (CNS) Nutrient Sensing in Diabetes
Chari, M. (2010) · TSpace (University of Toronto)
Central Nervous System Nutrient-sensing and the Regulation of Energy and Glucose Homeostasis
Lam, K. L. C. (2010) · TSpace (University of Toronto)
Dietary polyphenols: modulators of energy and substrate metabolism in obese humans
Most, J. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160115jm
In Vivo Role of JAK2 in the Pathogenesis of Obesity and the Metabolic Syndrome
Shi, S. Y. (2015) · TSpace (University of Toronto)
The Role of p21-activated Protein Kinase 1 in Metabolic Homeostasis
Chiang, Y. P. (2014) · TSpace (University of Toronto)
The metabolic effects of leptin therapy and glucagon suppression therapy in mouse models of diabetes
Neumann, U. H. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0348695
Linnartz, K. (2005) · RWTH Publications (RWTH Aachen)
Gold nanoparticles to ameliorate obesity related glucose intolerance
Ng, J. P. M. (2016) · UTS ePRESS (University of Technology Sydney)
Die molekulare Basis der intra- und extrazellulären Cholesterin-Homöostase
Miserez, A. (2001) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2001.04083
Weight regulation: physiology and pathophysiology
Hameed, S., & Dhillo, W. S. (2011) · doi:10.1093/med/9780199235292.003.1227
SREBP as a global regulator for lipid metabolism = 지질대사 조절에서 SREBP의 역할
Lee, W., & Seo, Y. (2018) · KRIBB Repository · doi:10.5352/jls.2018.28.10.1233
Sterol Regulatory Element-Binding Protein (SREBP) and Sugar and Lipid Metabolism.
一哉, 山., & Noguchi, T. (2002) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.55.45
Protein Modifications and Lifestyle Disorders
Arora, S., & Katyal, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00004-7
Urrego, C. C. A. (2013) · Buleria (Universidad de León) · doi:10.18002/10612/5726
Moreira, R. J. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2019.tde-27052019-143045
Schinner, S. (2010) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver
Non-coding RNAs Related to Obesity
Holvoet, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-68844-8_2
Diabetes mellitus, obesity and Adipocytokines: Pathophysio-logical perspectives.
Sohail, S., Javaid, A., Khan, T. A., Zahir, H., & Hussain, Z. (2019) · International Journal of Biology and Biotechnology
Ectopic Fat and the Metabolic Syndrome
Toledo, F. G. S., & Kelley, D. E. (2007) · Springer eBooks · doi:10.1007/978-0-387-32164-6_7
Chai, B. K., Murugan, D. D., Rais, M. M., Alshagga, M. A., & Mohankumar, S. K. (2022) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-211562
Syndromes of Extreme Insulin Resistance
Grunberger, G., Myneni, A., & Alfonso, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_17
Syndromes of Extreme Insulin Resistance
Grunberger, G., & Myneni, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_17-1
Ahima, R. S., Scolaro, L. M., & Park, H.-K. (2017) · Springer eBooks · doi:10.1007/978-3-319-12125-3_24-2
Leptin and its mechanism of action
Panić, A., Šoškić, S., & Isenović, E. R. (2015) · Medicinska istrazivanja · doi:10.5937/medist1502036p
Die molekulare Basis der intra- und extrazellulären Cholesterin-Homöostase
Miserez, A. (2001) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2001.04083
内科 １００年のあゆみ 内分泌・代謝 ＩＩＩ． 主要疾患の歴史 ８． 高脂血症
博仁, 曽., & 信博, 山. (2002) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.91.1202
Linder, J. E., Usmani, A., Miteva, M., Ricordi, C., & Romanelli, P. (2010) · Springer eBooks · doi:10.1007/978-1-60761-181-3_9
Glykogenspeichererkrankungen, Lipodystrophien und andere Fettgewebserkrankungen
Steinmetz, A., & Schmidt, H. (2007) · Springer eBooks · doi:10.1007/978-3-540-48554-4_42
Simha, V., & Garg, A. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_22
Metadata
- Authors
- Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Brown, Michael S.
- Goldstein, Joseph L.
- Venue
- Nature
- Published
- 1999-09
- Volume
- 401
- Issue
- 6748
- Pages
- 73-76
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1492605893
- Cited by
- 1,038
- References
- 15
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 22 · 2023: 24 · 2022: 19 · 2021: 20 · 2020: 20 · 2019: 23 · 2018: 31 · 2017: 29 · 2016: 30 · 2015: 38 · 2014: 36 · 2013: 39 · 2012: 43
- FWCI
- 23.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- leptin, congenital generalized lipodystrophy, insulin resistance, diabetes mellitus, transgenic mouse model, adipose tissue, hyperinsulinemia, hyperglycemia, hepatic steatosis, glucose disposal, dietary restriction, energy metabolism
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Disease Models, Animal, DNA-Binding Proteins, Female, Food Deprivation, Humans, Insulin Resistance, Lipodystrophy, Liver, Male, Mice, Obese, Mice, Transgenic, Nuclear Proteins, Promoter Regions, Genetic, Proteins, Transcription Factors, Adipocytes, Leptin, CCAAT-Enhancer-Binding Proteins, Mice, Sterol Regulatory Element Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
